MTEMQ (Molecular Templates) Cyclically Adjusted Revenue per Share: $34.48 (As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MTEMQ Molecular Templates Inc MTEMQ
12 GF Score
Price $0.00
View Full Analysis

What is Molecular Templates Cyclically Adjusted Revenue per Share?

Molecular Templates MTEMQ 12 Cyclically Adjusted Revenue per Share is $34.48 as of Jun. 2024. GuruFocus rates MTEMQ with a GF Score™ of 12/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Molecular Templates's adjusted revenue per share for the three months ended in Jun. 2024 was $0.029. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $34.48 for the trailing ten years ended in Jun. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-22), Molecular Templates's current stock price is $0.0001. Molecular Templates's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2024 was $34.48. Molecular Templates's Cyclically Adjusted PS Ratio of today is 0.00.


Molecular Templates  (OTCPK:MTEMQ) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Molecular Templates's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.0001/34.48
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Molecular Templates Cyclically Adjusted Revenue per Share Related Terms


Molecular Templates Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Molecular Templates's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Molecular Templates Cyclically Adjusted Revenue per Share Chart

Molecular Templates Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.35 38.03 38.33 39.00 36.45

Molecular Templates Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.63 37.82 36.45 35.76 34.48

MTEMQ vs GRTSQ, ARTHQ, VRTX: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, Molecular Templates's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Molecular Templates Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Molecular Templates's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Molecular Templates's Cyclically Adjusted PS Ratio falls into.


MTEMQ
12GF Score
Molecular Templates Inc MTEMQ
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Molecular Templates Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Molecular Templates's adjusted Revenue per Share data for the three months ended in Jun. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=0.029/314.1750*314.1750
=0.029

Current CPI (Jun. 2024) = 314.1750.

Molecular Templates Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201409 9.866 238.031 13.022
201412 9.586 234.812 12.826
201503 9.111 236.119 12.123
201506 8.345 238.638 10.986
201509 8.499 237.945 11.222
201512 128.660 236.525 170.898
201603 0.000 238.132 0.000
201606 0.000 241.018 0.000
201609 0.000 241.428 0.000
201612 0.000 241.432 0.000
201703 0.000 243.801 0.000
201706 6.912 244.955 8.865
201709 0.542 246.819 0.690
201712 0.000 246.524 0.000
201803 0.128 249.554 0.161
201806 0.523 251.989 0.652
201809 1.101 252.439 1.370
201812 1.668 251.233 2.086
201903 2.619 254.202 3.237
201906 2.123 256.143 2.604
201909 1.294 256.759 1.583
201912 1.732 256.974 2.118
202003 0.592 258.115 0.721
202006 1.982 257.797 2.415
202009 1.315 260.280 1.587
202012 1.049 260.474 1.265
202103 0.919 264.877 1.090
202106 4.047 271.696 4.680
202109 0.635 274.310 0.727
202112 4.785 278.802 5.392
202203 2.261 287.504 2.471
202206 1.176 296.311 1.247
202209 1.129 296.808 1.195
202212 0.695 296.797 0.736
202303 8.950 301.836 9.316
202306 1.764 305.109 1.816
202309 1.125 307.789 1.148
202312 1.233 306.746 1.263
202403 1.557 312.332 1.566
202406 0.029 314.175 0.029

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $34.48 mean?
Molecular Templates (MTEMQ) has a Cyclically Adjusted Revenue per Share of $34.48 as of Jun. 2024. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Molecular Templates and its competitors.
Is Molecular Templates' Cyclically Adjusted Revenue per Share too high?
Molecular Templates' current Cyclically Adjusted Revenue per Share is $34.48. Overall, Molecular Templates has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Molecular Templates' Cyclically Adjusted Revenue per Share compare to GRTSQ and ARTHQ?
Molecular Templates' Cyclically Adjusted Revenue per Share of $34.48 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Molecular Templates and its competitors. Molecular Templates's current Cyclically Adjusted Revenue per Share is $34.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Molecular Templates stock overvalued right now?
Molecular Templates (MTEMQ) has a current Cyclically Adjusted Revenue per Share of $34.48. The current Cyclically Adjusted Revenue per Share is $34.48. Molecular Templates' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Molecular Templates (MTEMQ), the current Cyclically Adjusted Revenue per Share is $34.48 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Molecular Templates Business Description

Address 9301 Amberglen Boulevard, Suite 100, Austin, TX, USA, 78729
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.
12GF Score

Get the complete analysis for MTEMQ

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price